Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Telmisartan for Alzheimer's Prevention in African Americans
NCT02471833Phase 2Completed
- Sponsor
- Emory University
- Start
- Apr 2015
- Primary completion
- Apr 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of telmisartan in Alzheimer's disease (AD), sponsored by Emory University. Started Apr 2015; status: completed.
02
Drugs
telmisartan
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT02471833.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02471833.